{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:41:43Z","timestamp":1787071303999,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p>Use of metformin throughout pregnancy in women with polycystic ovary syndrome (PCOS) has shown to reduce the rates of early pregnancy loss, preterm labor, and prevention of fetal growth restriction. Metformin has been shown to have encouraging effects on several metabolic aspects of polycystic ovarian syndrome, such as insulin sensitivity, plasma glucose concentration and lipid profile and since women with PCOS are more likely than healthy women to suffer from pregnancy-related problems like early pregnancy loss, gestational diabetes mellitus and hypertensive states in pregnancy, the use of metformin therapy in these patients throughout pregnancy may have beneficial effects on early pregnancy loss and development of gestational diabetes.<\/jats:p>","DOI":"10.4103\/0974-1208.101012","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T00:58:07Z","timestamp":1347670687000},"page":"166-169","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Effects of metformin use in pregnant patients with polycystic ovary syndrome"],"prefix":"10.4103","volume":"5","author":[{"given":"Pratap","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250926","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20250926","first-page":"63","article-title":"Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation","volume":"60","author":"Goldenberg","year":"2008","journal-title":"Minerva Ginecol"},{"key":"R3-20250926","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20250926","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"R5-20250926","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250926","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250926","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: A randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20250926","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","article-title":"The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications","volume":"157","author":"De Leo","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R9-20250926","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/00016340600780441","article-title":"Polycystic ovary syndrome and metformin in pregnancy","volume":"85","author":"Lilja","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R10-20250926","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000268051","article-title":"Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome","volume":"69","author":"Nawaz","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"R11-20250926","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"R12-20250926","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1447-0756.2008.00856.x","article-title":"Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?","volume":"34","author":"Nawaz","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"R13-20250926","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00431-008-0737-7","article-title":"Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity","volume":"168","author":"Bolton","year":"2009","journal-title":"Eur J Pediatr"},{"key":"R14-20250926","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/01.AOG.0000163249.65810.5b","article-title":"Excretion of metformin into breast milk and the effect on nursing infants","volume":"105","author":"Briggs","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R15-20250926","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jpeds.2006.01.011","article-title":"Growth, motor, and social development in breast and formula-fed infants of metformin-treated women with polycystic ovary syndrome","volume":"148","author":"Glueck","year":"2006","journal-title":"J Pediatr"},{"key":"R16-20250926","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2007.06.079","article-title":"Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: A prospective clinical study","volume":"90","author":"Zolghadri","year":"2008","journal-title":"Fertil Steril"},{"key":"R17-20250926","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0015-0282(98)00007-7","article-title":"Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function","volume":"69","author":"Okon","year":"1998","journal-title":"Fertil Steril"},{"key":"R18-20250926","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-0528.1993.tb12978.x","article-title":"Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: Prospective study in 50 women","volume":"100","author":"Tulppala","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"R19-20250926","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20250926","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/09513590902770172","article-title":"Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome","volume":"25","author":"Billa","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"R21-20250926","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.08.087","article-title":"Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"92","author":"Palomba","year":"2009","journal-title":"Fertil Steril"},{"key":"R22-20250926","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: Purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"R23-20250926","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/14647270701731290","article-title":"Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines","volume":"10","author":"Balen","year":"2007","journal-title":"Hum Fertil (Camb)"},{"key":"R24-20250926","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1447-0756.2008.00876.x","article-title":"Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome","volume":"35","author":"Begum","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"R25-20250926","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.fertnstert.2007.03.036","article-title":"Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome","volume":"89","author":"Glueck","year":"2008","journal-title":"Fertil Steril"},{"key":"R26-20250926","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/09513590.2010.540600","article-title":"Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome.? Prospective cohort study","volume":"27","author":"Khattab","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"R28-20250926","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1471-0528.2010.02763.x","article-title":"Metformin should be considered in the treatment of gestational diabetes: A prospective randomised study","volume":"118","author":"Ij\u00e4s","year":"2011","journal-title":"BJOG"},{"key":"R29-20250926","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/met.2004.2.192","article-title":"Effect of metformin in asian Indian women with polycystic ovarian syndrome","volume":"2","author":"Misra","year":"2004","journal-title":"Metab Syndr Relat Disord"},{"key":"R30-20250926","first-page":"25","article-title":"Our experience in the treatment of polycystic ovary syndrome with Metformin","volume":"40","author":"Mitkov","year":"2001","journal-title":"Akush Ginekol (Sofiia)"},{"key":"R31-20250926","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"R32-20250926","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjopharm.2005.12.002","article-title":"Possible metformin-induced hepatotoxicity","volume":"3","author":"Kutoh","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"key":"R33-20250926","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4158\/EP.9.4.307","article-title":"Metformin-induced cholestatic hepatitis","volume":"9","author":"Nammour","year":"2003","journal-title":"Endocr Pract"},{"key":"R34-20250926","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/j.1572-0241.2001.03972.x","article-title":"Cholestatic jaundice associated with the use of metformin","volume":"96","author":"Desilets","year":"2001","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363858-201205020-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:22Z","timestamp":1787067862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363858-201205020-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4103\/0974-1208.101012","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"2011-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}